Novartis India

71
Buy
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE234A01025
  • NSEID: NOVARTIND
  • BSEID: 500672
INR
1,609.70
-25.2 (-1.54%)
BSENSE

Aug 06, 03:30 PM

BSE+NSE Vol: 29.0 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 6.33% vs -11.53% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 40.09% vs 0.28% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -48.32% vs -14.86% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 18.44% vs -17.58% in Mar 2024

Compare Profit and Loss Results of Novartis India
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
356.00
257.00
99.00
38.52%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
356.00
257.00
99.00
38.52%
Expenditure (Ex Depriciation)
Stock Adjustments
3.00
-16.00
19.00
118.75%
Raw Materials Consumed
199.00
171.00
28.00
16.37%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
18.00
31.00
-13.00
-41.94%
Operating Expenses
8.00
4.00
4.00
100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
10.00
15.00
-5.00
-33.33%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
9.00
0.00
9.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
264.00
245.00
19.00
7.76%
Operating Profit (PBDIT) excl Other Income
91.00
11.00
80.00
727.27%
Other Income
41.00
4.00
37.00
925.00%
Operating Profit (PBDIT)
133.00
16.00
117.00
731.25%
Interest
0.00
1.00
-1.00
-100.00%
Profit before Depriciation and Tax
132.00
15.00
117.00
780.00%
Depreciation
2.00
3.00
-1.00
-33.33%
Profit Before Taxation & Exceptional Items
130.00
11.00
119.00
1,081.82%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
130.00
11.00
119.00
1,081.82%
Provision for Tax
29.00
3.00
26.00
866.67%
Profit After Tax
100.00
8.00
92.00
1,150.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
728.00
30.00
698.00
2,326.67%
Profit Available for appropriations
829.00
38.00
791.00
2,081.58%
Appropriations
829.00
38.00
791.00
2,081.58%
Equity Dividend (%)
500%
10%
490.00
Earnings Per Share
40.87
3.16
37.71
1,193.35%
Profit And Loss - Net Sales
Net Sales 356.27 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 6.33% vs -11.53% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 91.42 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 40.09% vs 0.28% in Mar 2024

Profit And Loss - Interest
Interest 0.77 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -48.32% vs -14.86% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 100.90 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 18.44% vs -17.58% in Mar 2024